TPTW yields 2000000.00% · ABBV yields 3.06%● Live data
📍 TPTW pulled ahead of the other in Year 1
Combined, TPTW + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TPTW + ABBV for your $10,000?
TPT Global Tech, Inc. operates as a media content hub for domestic and international syndication technology/telecommunications companies worldwide. It also provides technology solutions for businesses. The company offers software as a service (SaaS), technology platform as a service (PAAS), cloud-based unified communication as a service (UCaaS), and carrier-grade performance and support services for businesses over its private IP MPLS fiber and wireless network. Its cloud-based UCaaS services allow businesses to access voice, data, media, and collaboration in technology markets. In addition, the company distributes pre-paid cellphone services, mobile phones, cellphone accessories, and global roaming cellphones for nationwide mobile virtual network operators and independent sales organization. Additionally, it offers phone, Internet, fiber optic, wireless, hosted PBX, Wi-Fi, Wi-Max, engineering, cabling, wiring, and cloud services; hosted firewall and managed MPLS service technologies; and enterprise-class integrated solutions for manufacturers, retailers, and distributors. Further, the company provides cloud unified businesses services that delivers global TV broadcast and social media platform utilizing a mobile app technology on its proprietary content delivery network; and creates original live action and animated content productions for television, theatrical, home entertainment, and new media markets, as well as operates as an Internet service provider. Additionally, it develops point-of-care diagnostics or testing products, including SANIQuik, a decontamination and sanitizing unit and QuikLAB mobile laboratories. The company was formerly known as Ally Pharma US, Inc. and changed its name to TPT Global Tech, Inc. in December 2014. TPT Global Tech, Inc. is headquartered in San Diego, California.
Full TPTW Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.